• English
  • Português
  • Español

Beriplex® Administration in Neonatal & Pediatric Emergencies: A Clinical Reference Guide & Protocol Toolkit

📄 Download the full clinical reference (PDF)Download PDF
Yellow cover page titled 'Beriplex® Administration in Neonatal & Pediatric Emergencies: A Clinical Reference Guide & Protocol Toolkit' with Royal Children's Hospital Melbourne and NeoFast logos.

Beriplex® Administration in Neonatal & Pediatric Emergencies

A Clinical Reference Guide & Protocol Toolkit

Source: The Royal Children’s Hospital Melbourne – Beriplex® (Human prothrombin complex) guideline for neonatal and paediatric patients | Augmented with NeoFast Clinical Decision Support tool.

The Coagulation Cluster & Clinical Indications

Diagram of the coagulation factor cluster with half-lives, a note on 5-minute peak plasma concentration, and a comparison table of standard CSL indications versus RCH-specific pediatric indications for Beriplex.

The Coagulation Cluster

  • Factor II (Half-life: 60h)
  • Factor VII (Half-life: 4.2h)
  • Protein C (Inhibitor)
  • Protein S (Inhibitor)
  • Factor X (Half-life: 31h)
  • Factor IX (Half-life: 17h)

5 Minutes

Peak plasma concentrations occur within five minutes of infusion.

Note: Prepared from human plasma. Blood transfusion consent should be sought where possible.

Clinical Indications: Standard vs. Pediatric Protocol

Standard CSL IndicationsRCH Specific Indications
Treatment of bleeding due to acquired prothrombin complex deficiency.Emergency DOAC reversal (Direct-Acting Oral Anticoagulants).
Reversal of vitamin K antagonists (e.g., warfarin) in perioperative or bleeding contexts.Vitamin K Deficiency Bleeding (VKDB) of the newborn.
Treatment of VKA overdose.Cardiopulmonary bypass bleeding.
Patient/family refusal of whole blood products.

Critical Cautions & Contraindications

List of absolute contraindications for Beriplex including heparin-induced thrombocytopenia, active DIC, and hypersensitivity, alongside a list of cautions requiring risk balancing such as neonates, thrombosis history, CVAD, and liver disease.

Critical Cautions & Contraindications

Absolute Contraindications

  • History of Heparin Induced Thrombocytopenia (HIT) (Beriplex contains Heparin)
  • Active Disseminated Intravascular Coagulation (DIC) (Only consider after resolution of the consumptive state)
  • Hypersensitivity to product components

Cautions (Risk Balancing)

  • Neonates (specifically noted as a caution group)
  • Patients with a history of thrombosis or prothrombotic state
  • Presence of a Central Venous Access Device (CVAD)
  • Patients with liver disease

Focus on Neonates: Vitamin K Deficiency Bleeding (VKDB)

Flowchart showing VKDB clinical condition, threshold of any INR ≥1.5, and required action of Beriplex 50 IU/kg plus Vitamin K 1mg, alongside two NeoFast app screenshots demonstrating dose entry and calculated reconstitution results.

Focus on Neonates: Vitamin K Deficiency Bleeding (VKDB)

Clinical ConditionClinical ThresholdRequired Action
Vitamin K Deficiency Bleeding (VKDB) in infants. Specifically: major bleeding or refractory to standard treatment.
*In severe cases and very-low-birth-weight infants, delivered vitamin K utilisation may be insufficient due to immature liver function.		Any INR ≥ 1.5Beriplex® 50 IU/kg
Vitamin K 1mg (IV or PO)

NeoFast App Workflow

  • Select Beriplex® (Factor II + Factor VII + Factor IX + Factor X), Emergency procedure, Intermittent IV, 250UI/10mL Powder.
  • Enter Weight (kg): 2
  • Enter Desired dose (UI/kg): 50 — Suggested dose range: 20 to 50
  • Callout: “Put on the desired weight and dose to get the results in seconds.”
  • Result screen: Dose 100UI; Reconstitute with own Specific diluent 10mL; Concentration after reconstitution 25mg/mL; Dose after reconstitution 4mL; Infusion rate 50min.
  • Note: reconstitute the 250 IU ampoule with a 10 mL diluent to obtain a concentration of 25 UI/mL. The dose shown in mL is after reconstitution. Do not redilute. The maximum infusion rate is 3 UI/kg/min, 1 UI/kg/min has been adopted.

Dosing Algorithm: Anticoagulant Reversal

Table showing dosing algorithm for anticoagulant reversal based on clinical condition/severity and INR parameters, plus rules for rounding by weight, and NeoFast app screenshots for selecting indication and entering weight/dose.

Dosing Algorithm: Anticoagulant Reversal

Clinical Condition/SeverityClinical ParametersRecommended Dose
Critical/Major Bleeding (Critical organ/life-threatening on Warfarin OR Major DOAC bleeding)Any INR ≥ 1.550 IU/kg (Max 5000 IU)
Urgent Peri-operative OR Major Bleeding on WarfarinPre-treatment INR 2.0 – 3.925 IU/kg (Max 2500 IU)
Urgent Peri-operative OR Major Bleeding on WarfarinPre-treatment INR 4.0 – 6.035 IU/kg (Max 3500 IU)
Urgent Peri-operative OR Major Bleeding on WarfarinPre-treatment INR ≥ 6.050 IU/kg (Max 5000 IU)

Rules: Based on weight up to 100kg. If >15kg, round to nearest vial size. If ≤15kg, round to nearest 25 IU or 50 IU.

NeoFast App Workflow

  • Select Beriplex® (Factor II + Factor VII + Factor IX + Factor X)
  • Choose indication from dropdown: Emergency procedure; Known pre-treatment INR: perioperative treatment and prophylaxis of bleeding during vitamin K+ antagonist therapy; Reversal of direct oral anticoagulants [off-label]
  • Select route: Intermittent IV; vial size 250UI/10mL Powder, 500UI/20mL Powder, 1,000UI/40mL Powder
  • Enter Weight (kg) and Desired dose (UI/kg)
  • Callout: “Choose the indication and fill in with the desired weight and dose to obtain safe calculations in seconds.”

Preparation & Reconstitution Protocol; Administration Parameters

Three-step flow showing Beriplex vial presentation, reconstitution with Mix2Vial system, and the critical constraint not to further dilute, plus an infusion speed gauge showing maximum rate of 210 IU/minute and a checklist for administration.

Preparation & Reconstitution Protocol

  • 1. Presentation: 500 IU vials paired with 20 mL water for injection.
  • 2. Reconstitution: Reconstitute using provided diluent and the Mix2Vial™ system. No antimicrobial preservatives—use immediately. (Multiple vials may be pooled into a single infusion)
  • 3. Critical Constraint: DO NOT further dilute Beriplex®.

Administration Parameters

Absolute Maximums

  • Maximum Rate: 210 IU/minute
  • Volume Equivalent: Approx 8 mL/minute

Max 3 IU/kg/min — Strict Infusion Speed Limit

Checklist

  • Method: Slow IV push.
  • Line Requirement: Must administer via a separate IV line. Do not mix with other medicinal products.
  • Post-Admin: Check INR within 30 minutes post-warfarin reversal.

The High-Stakes Calculation Gap & Introducing NeoFast

Crossed-out manual dosage calculation formula labeled 'Error Risk', with explanatory boxes on variables, constraints, and reality of manual calculation, followed by an introduction to the NeoFast app and its benefits, shown alongside a phone screenshot of the app.

The High-Stakes Calculation Gap

Patient Weight (kg) × Target Dose (IU/kg) ÷ Reconstituted Concentration (mg/mL) = Output Volume — ERROR RISK

The VariablesThe ConstraintsThe Reality
Calculating exact IU/kg doses while converting to mL based on reconstitution concentration.Must round to nearest 25/50 IU for neonates. Must calculate maximum safe infusion rate (3 IU/kg/min).Performing multistep mathematical conversions while managing a critical neonatal bleed introduces an unacceptable risk for human error.

Introducing NeoFast: Precision at the Point of Care

  • Eliminates manual dosage arithmetic.
  • Automatically accounts for specific pediatric rounding rules.
  • Calculates exact reconstitution volumes and safe infusion times instantly.

Step 1: Rapid Clinical Input; Step 2: Instant, Error-Free Output

Two-step guide to using the NeoFast app: entering procedure type, weight, and desired dose in Step 1, and viewing the automatically calculated total dose, reconstitution formula, syringe draw volume, and safe infusion rate in Step 2.

Step 1: Rapid Clinical Input

  • Field 1: Procedure Type (e.g., Emergency procedure).
  • Field 2: Patient Weight (e.g., 2 kg).
  • Field 3: Desired Dose (e.g., 20 UI/kg). The app provides a safety guardrail by displaying the suggested clinical range (20 to 50 UI/kg) right below the input.

Step 2: Instant, Error-Free Output

  • Total Dose: 40 UI (Automatically calculated for rounding rules).
  • Reconstitution Formula: Reconstitute with 10mL to achieve an exact 25mg/mL concentration.
  • Syringe Draw (Volume): Exactly 1.6 mL to administer.
  • Safe Infusion Rate: 20 minutes. (Note: NeoFast adopts a highly conservative 1 UI/kg/min baseline to ensure absolute safety against the 3 UI/kg/min maximum.)

Note: reconstitute the 250 IU ampoule with a 10 mL diluent to obtain a concentration of 25 UI/mL. The dose shown in mL is after reconstitution. Do not redilute. The maximum infusion rate is 3 UI/kg/min, 1 UI/kg/min has been adopted.

Programmed for Complexity

Screenshot of the NeoFast app medicines module showing selection of Beriplex and the off-label reversal of direct oral anticoagulants clinical condition with a list of result options.

Programmed for Complexity

  • Select the clinical condition and get the results
  • Reversal of direct oral anticoagulants [off-label]

NeoFast app screen (Medicines section):

  • Medicine: Beriplex® (FACTOR II + FACTOR VII + FACTOR IX + FACTOR X)
  • Clinical condition selected: Reversal of direct oral anticoagulants [off-label]

Available clinical condition options shown in dropdown:

  • Calculation with the desired factor X: bleeding and perioperative prophylaxis in congenital
  • Emergency procedure
  • Known pre-treatment INR: perioperative treatment and prophylaxis of bleeding during vitamin K+ antagonist therapy.
  • Reversal of direct oral anticoagulants [off-label]

NeoFast dynamically adapts its algorithms to align with specific institutional protocols, including off-label DOAC reversal, ensuring instant compliance without flipping through manuals.

The Clinical Summary Cheat Sheet

Cheat sheet infographic summarizing neonatal VKDB dosing, reversal dosing by INR range, administration rules, and app download links, followed by a global availability banner with world map and flag globe graphics.

The Clinical Summary Cheat Sheet

Neonatal VKDB FocusReversal Dosing
INR ≥ 1.5 → 50 IU/kg Beriplex + 1mg Vit K (Vitamin K dependent bleeding)
INR 2.0-3.9→ 25 IU/kg
INR 4.0-6.0→ 35 IU/kg
INR ≥6.0 or DOAC→ 50 IU/kg

Admin Rules

  • Max rate 3 IU/kg/min.
  • Do NOT further dilute.
  • Separate IV line required.

The Digital Advantage

  • Get it on Google Play
  • Download on the App Store
  • Download NeoFast App — Calculate instantly and safely with NeoFast.

Available in more than 178 countries! Out now!

neofast